{"id":"https://openalex.org/W4389246451","doi":"https://doi.org/10.1182/blood-2023-187374","title":"Venetoclax Resistance Results in Broad Resistance to Majority of Anti-MM Agents Due to the Suppression of Apoptosis but Can be Overcome By BCMA-Targeted Immunotherapy","display_name":"Venetoclax Resistance Results in Broad Resistance to Majority of Anti-MM Agents Due to the Suppression of Apoptosis but Can be Overcome By BCMA-Targeted Immunotherapy","publication_year":2023,"publication_date":"2023-11-02","ids":{"openalex":"https://openalex.org/W4389246451","doi":"https://doi.org/10.1182/blood-2023-187374"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2023-187374","doi":"https://doi.org/10.1182/blood-2023-187374","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1182/blood-2023-187374","pdf_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/3311/2199845/blood-9913-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/3311/2199845/blood-9913-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062468245","display_name":"Mariateresa Fulciniti","orcid":"https://orcid.org/0000-0002-1432-9742","observed_orcids":["https://orcid.org/0000-0002-1432-9742"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariateresa Fulciniti","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008198016","display_name":"Shuhui Deng","orcid":"https://orcid.org/0009-0007-6564-8552","observed_orcids":["https://orcid.org/0009-0007-6564-8552"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210147887","display_name":"Institute of Hematology & Blood Diseases Hospital","ror":"https://ror.org/04n16t016","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210147887"]},{"id":"https://openalex.org/I4391768267","display_name":"State Key Laboratory of Experimental Hematology","ror":"https://ror.org/0093mkr06","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4391768267"]}],"countries":["CN","US"],"is_corresponding":false,"raw_author_name":"Shuhui Deng","raw_affiliation_strings":["2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, CHN","3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, CHN","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I4210147887","https://openalex.org/I4391768267"]},{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011036815","display_name":"Sanika Dereibal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanika Dereibal","raw_affiliation_strings":["3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093399311","display_name":"Vera Joy Weiler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vera Joy Weiler","raw_affiliation_strings":["3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110257948","display_name":"Madhumouli Chatterjee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madhumouli Chatterjee","raw_affiliation_strings":["3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102586535","display_name":"Jessica Ng Fong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Ng Fong","raw_affiliation_strings":["3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110651995","display_name":"Chandraditya Chakraborty","orcid":"https://orcid.org/0009-0004-5865-9593","observed_orcids":["https://orcid.org/0009-0004-5865-9593"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chandraditya Chakraborty","raw_affiliation_strings":["3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056254084","display_name":"RAO H. PRABHALA","orcid":"https://orcid.org/0000-0002-6375-0437","observed_orcids":["https://orcid.org/0000-0002-6375-0437"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rao Prabhala","raw_affiliation_strings":["3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masood A. Shammas","raw_affiliation_strings":["3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","4VA Boston Heathcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"4VA Boston Heathcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071900604","display_name":"An\u0131l Akta\u015f-Samur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anil Aktas-Samur","raw_affiliation_strings":["3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041668980","display_name":"Mehmet Samur","orcid":"https://orcid.org/0000-0002-9978-5682","observed_orcids":["https://orcid.org/0000-0002-9978-5682"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet K. Samur","raw_affiliation_strings":["3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084463088","display_name":"Annamaria Gull\u00e0","orcid":"https://orcid.org/0000-0003-4569-0095","observed_orcids":["https://orcid.org/0000-0003-4569-0095"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annamaria Gulla","raw_affiliation_strings":["3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C Munshi","raw_affiliation_strings":["4VA Boston Heathcare System, Boston, MA","5Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4VA Boston Heathcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]},{"raw_affiliation_string":"5Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"142","issue":"Supplement 1","first_page":"3311","last_page":"3311"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax-resistance","display_name":"venetoclax resistance","score":0.984000027179718},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8299999833106995},{"id":"https://openalex.org/keywords/apoptosis-inhibition","display_name":"apoptosis inhibition","score":0.6000000238418579},{"id":"https://openalex.org/keywords/mitochondrial-priming","display_name":"mitochondrial priming","score":0.8849999904632568},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.7680000066757202},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.8569999933242798},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.9649999737739563},{"id":"https://openalex.org/keywords/bcl-w","display_name":"Bcl-w","score":0.9850000143051147},{"id":"https://openalex.org/keywords/building-information-modeling","display_name":"building information modeling","score":0.8019999861717224},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.6370000243186951},{"id":"https://openalex.org/keywords/bcma-cd3-bispecific-antibody","display_name":"BCMA-CD3 bispecific antibody","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9875540733337402},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6226361393928528},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.6209491491317749},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5299561619758606},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.470030277967453},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4447503387928009},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40583616495132446},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3785221576690674},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37522992491722107},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.28429844975471497},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.20052051544189453},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.19629067182540894}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2023-187374","doi":"https://doi.org/10.1182/blood-2023-187374","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1182/blood-2023-187374","pdf_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/3311/2199845/blood-9913-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2023-187374","doi":"https://doi.org/10.1182/blood-2023-187374","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1182/blood-2023-187374","pdf_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/3311/2199845/blood-9913-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389246451.pdf","grobid_xml":"https://content.openalex.org/works/W4389246451.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4399532431","https://openalex.org/W3097557104","https://openalex.org/W3212382166","https://openalex.org/W3107777078","https://openalex.org/W3211375514","https://openalex.org/W2983814742","https://openalex.org/W2747686060","https://openalex.org/W3214046330","https://openalex.org/W2981166293","https://openalex.org/W3005228069"],"abstract_inverted_index":{"Venetoclax":[0,70],"represents":[1],"the":[2,21,77,81,89,138,174,186,194,212,218,223,263,267,273,276,284,290,356,419,440],"first":[3],"example":[4],"of":[5,26,69,88,103,214,252,266,275,358,399,442],"personalized":[6],"medicine":[7],"in":[8,18,73,80,91,134,170,204,217,235,272,289,386,418,433,484,510,554],"multiple":[9,129],"myeloma":[10,144,491,535],"(MM),":[11],"as":[12,193,222,449],"it":[13],"has":[14],"meaningful":[15],"clinical":[16],"activity":[17],"patients":[19,27],"harboring":[20],"t(11;14)":[22,497],"translocation.":[23],"This":[24,348],"subgroup":[25],"generally":[28],"displays":[29],"upregulated":[30],"BCL-2":[31,219,373],"expression":[32,251],"and/or":[33],"a":[34,165,297,336,369,384,494,514],"higher":[35],"BCL-2/BCL-X":[36],"L":[37],"ratio,":[38],"reflecting":[39],"an":[40],"imbalance":[41],"between":[42,372],"cell":[43,49,163,179,183,416,462,482],"survival":[44,65,79,93],"(promoted":[45,51],"by":[46,52,111,473],"BCL-2)":[47],"and":[48,63,71,133,147,153,196,247,259,324,330,407,414,475,487,512,537,543],"death":[50,417,483],"BCL-X":[53,257],"L).":[54],"The":[55],"Bellini":[56],"study":[57],"demonstrated":[58],"significantly":[59,109],"superior":[60],"response":[61,112,516],"rate":[62],"progression-free":[64],"(PFS)":[66],"with":[67,83,100,164,232,426,496,520],"combination":[68,427],"Bortezomib":[72],"relapsed":[74],"myeloma,":[75],"however,":[76,105],"overall":[78,92],"arm":[82],"venetoclax":[84,121,151,187,359,447,529],"was":[85,95,293],"inferior.":[86],"Part":[87],"decrease":[90],"(OS)":[94],"considered":[96],"to":[97,113,125,128,149,167,173,300,310,339,344,352,394,423,445,460,505,528,533,558],"be":[98,363,391],"related":[99],"increased":[101,249,411],"incidence":[102],"infections,":[104],"OS":[106],"is":[107],"also":[108,242,294],"impacted":[110],"subsequent":[114,130],"therapies.":[115],"Here,":[116],"we":[117,376,524],"investigated":[118,439],"whether":[119],"acquired":[120,556],"resistance":[122,127,188,299,338,360,448,527,532,557],"could":[123],"lead":[124],"global":[126],"anti-MM":[131,313],"therapies":[132],"turn":[135],"can":[136,390],"explain":[137],"decreased":[139],"OS.":[140],"We":[141,280,303,437,464],"exposed":[142],"venetoclax-sensitive":[143],"cells":[145,176,198,292,388,479,492,509,542],"(KMS27":[146],"KMS12PE)":[148],"high-dose":[150],"treatment":[152],"generated":[154],"monoclonal":[155,545],"drug-tolerant":[156],"expanded":[157],"persister":[158],"(DTEP)":[159],"clones":[160,180,241,307,421,486],"from":[161,493],"single":[162,178,424],"three-":[166],"ten-fold":[168],"increase":[169],"IC50":[171],"compared":[172,422],"parental":[175,195,333,488],"(4":[177],"for":[181,296],"each":[182],"line).":[184],"Interestingly,":[185],"evolved":[189],"without":[190],"genomic":[191,215],"alterations,":[192],"resistant":[197,240,291,309,387,420],"did":[199],"not":[200,362,453],"show":[201],"marked":[202],"differences":[203],"mutational":[205],"frequencies":[206],"or":[207,228,326,381,403],"copy":[208],"number":[209],"variations,":[210],"including":[211,255,315],"absence":[213],"alterations":[216],"gene,":[220],"such":[221],"Gly101Val":[224],"mutation,":[225],"1q21":[226],"gain":[227],"8p":[229],"loss.":[230],"Consistent":[231],"previous":[233],"literature":[234],"other":[236],"disease":[237],"models,":[238],"these":[239,353,366,450],"exhibited":[243],"reduced":[244,345],"mitochondrial":[245,286],"priming":[246,287],"had":[248],"protein":[250],"anti-apoptotic":[253,268],"regulators,":[254],"MCL-1,":[256],"L,":[258],"BCL-W,":[260],"thus":[261,550],"overcoming":[262],"venetoclax-induced":[264],"inhibition":[265,398],"regulator":[269],"BCL-2,":[270],"resulting":[271],"sequestration":[274],"pro-apoptotic":[277],"ligand":[278],"BIM.":[279],"next":[281,377],"evaluated":[282,378],"if":[283,379],"altered":[285],"observed":[288,304,465],"responsible":[295],"broader":[298],"anti-cancer":[301,340],"agents.":[302],"that":[305,350,389,466,526,538],"venetoclax-resistant":[306,485],"were":[308],"most":[311],"standard-of-care":[312,534],"agents":[314,317,341,354],"alkylating":[316],"(Melphalan,":[318],"cyclophosphamide,":[319],"bendamustine),":[320],"proteasome":[321],"inhibitors":[322],"(bortezomib":[323],"carfilzomib)":[325],"immunomodulatory":[327],"drugs":[328,536],"(lenalidomide":[329],"pomalidomide)":[331],"than":[332],"cells,":[334],"suggesting":[335],"broad":[337,531],"possibly":[342],"due":[343],"apoptotic":[346,458],"signaling.":[347],"indicates":[349],"switching":[351],"after":[355],"acquisition":[357],"may":[361,547],"efficacious.":[364],"Since":[365],"data":[367],"suggested":[368],"functional":[370],"substitution":[371],"family":[374],"members,":[375],"MCL1":[380,400],"BCL-XL":[382,404],"represent":[383],"co-dependency":[385],"therapeutically":[392],"targeted":[393],"overcome":[395,446],"resistance.":[396],"Simultaneous":[397],"(via":[401,405,409],"S63845)":[402],"A155463)":[406],"BCL2":[408],"venetoclax)":[410],"BIM":[412],"release":[413],"enhanced":[415],"agents,":[425],"index":[428],"(CI)":[429],"values":[430],"<":[431],"0.3":[432],"all":[434],"doses":[435],"tested.":[436],"further":[438],"efficacy":[441],"immunotherapeutic":[443],"approaches":[444],"immunotherapies":[451],"do":[452],"rely":[454],"exclusively":[455],"on":[456,500],"traditional":[457],"signaling":[459],"mediate":[461],"death.":[463],"both":[467],"antibody-dependent":[468],"cellular":[469],"cytotoxicity":[470,504],"(ADCC)":[471],"induced":[472,480],"Daratumumab":[474],"BCMA":[476],"targeting":[477],"CAR-T":[478,541],"comparable":[481],"cells.":[489],"Moreover,":[490],"patient":[495],"MM":[498],"progressing":[499],"venetoclax,":[501],"showed":[502],"significant":[503],"anti-BCMA":[506],"CAR":[507],"T":[508],"vitro":[511],"achieved":[513],"deep":[515],"subsequently":[517],"when":[518],"treated":[519],"Cilta-cel.":[521],"In":[522],"conclusion,":[523],"report":[525],"confers":[530],"immunotherapies,":[539],"especially":[540],"CD38":[544],"antibody,":[546],"remain":[548],"effective,":[549],"conferring":[551],"potential":[552],"benefits":[553],"managing":[555],"venetoclax.":[559]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-12-02T00:00:00"}